Henry Meds vs Mochi Health vs Remedy Meds (2026)

On tirzepatide, the order is Mochi Health↗ ($278) → Henry Meds↗ ($349) → Remedy Meds↗ ($399) — gaps of $71 and then $50 a month, a $1,452 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

Mochi Health: the record, condensed

On tirzepatide, the number that matters at Mochi Health is $278 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

A required $79/month membership is part of the deal, and part of the figure above: $199 of medication plus $79 of platform equals the $278 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #4 of 17 verified programs, with the floor $63/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.

On semaglutide, the number that matters at Mochi Health is $178 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Mochi Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Inside that $178 sits a mandatory $79-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $99, and it is not a price anyone can actually pay, because the membership cannot be declined.

Context for that figure: it ranks #8 of 20 in the verified semaglutide index — $45/month above the floor (Oak Longevity, $133) — and sits $171 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,136.

Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗

Henry Meds: the record, condensed

On tirzepatide, the number that matters at Henry Meds is $349 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Henry Meds is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $349 is the whole subscription, which makes Henry Meds unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #10 of 17 in the verified tirzepatide index — $134/month above the floor (NexLife, $215) — and sits $100 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,188.

Start with the load-bearing figure: $179 a month, all-in, is what Henry Meds charges for semaglutide at the 2.4 mg basis. It is a flat structure: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

There is no membership line. $179 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #9 of 20 verified programs, with the floor $46/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $170 a month. A year at this figure: $2,148 monthly-billed.

Operationally at Henry Meds: shipping included; commitment none month-to-month; cancellation check terms before prepaying; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Henry Meds page · visit Henry Meds ↗

Remedy Meds: the record, condensed

Remedy Meds’s tirzepatide program bills $399 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

There is no membership line. $399 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #15 of 17 in the verified tirzepatide index — $184/month above the floor (NexLife, $215) — and sits $50 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,788.

Remedy Meds’s semaglutide program bills $299 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Remedy Meds is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #19 of 20 verified programs, with the floor $166/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $50 a month. A year at this figure: $3,588 monthly-billed.

Operationally at Remedy Meds: shipping included; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Remedy Meds page · visit Remedy Meds ↗

§ The three-way read

Prices, gaps, and what sits inside them

Mochi Health holds the low ground at $278 — dose-flat, so that figure is a ceiling (its $79 membership already inside). Henry Meds follows at $349 (+$71/mo, $852/yr). Remedy Meds tops the trio at $399 (+$121/mo over the leader, $1,452/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles nothing: Mochi Health $178 → Henry Meds $179 → Remedy Meds $299 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: Mochi Health ($278); cheapest 12-month path: Mochi Health ($3,336); simplest billing (no membership): Henry Meds and Remedy Meds; named-pharmacy transparency: Mochi Health; cheapest semaglutide of the three: Mochi Health ($178).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Mochi Health vs Henry Meds · Mochi Health vs Remedy Meds · Henry Meds vs Remedy Meds.

§ Structure, three ways

Everything besides the three prices

Memberships: Mochi Health $79/mo (inside its figure); Henry Meds none; Remedy Meds none. Structures: Mochi Health dose-flat; Henry Meds dose-flat; Remedy Meds dose-flat. Pharmacies: Mochi Health named (company-owned compounding facility); Henry Meds not named; Remedy Meds not named. States: Mochi Health — most states; Henry Meds — most states; Remedy Meds — not published. Exit terms: Mochi Health — cancel membership any time; recurs until cancelled; Henry Meds — check terms before prepaying; Remedy Meds — not published.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Mochi Health source-verified (2026-08-05); Henry Meds third-party reported (2026-08-05); Remedy Meds third-party reported (2026-08-05).

The trio on semaglutide, across time

3 mo: Mochi Health $534 vs Henry Meds $537 vs Remedy Meds $897 6 mo: Mochi Health $1,068 vs Henry Meds $1,074 vs Remedy Meds $1,794 12 mo: Mochi Health $2,136 vs Henry Meds $2,148 vs Remedy Meds $3,588 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

Mochi Health: $3,336/yr monthly-billed; Henry Meds: $4,188/yr monthly-billed; Remedy Meds: $4,788/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $2,904 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

Work it as eliminations rather than a beauty contest. Remedy Meds enters owing an explanation: $121/month above Mochi Health compounds to $1,452 a year — real therapy-months of money — so its record has to name what the premium buys (structure the cheaper two lack) or it exits first. Henry Meds survives the first cut only to face the harder question — whether nothing structural — its case is purely situational is worth $71 a month to you — because a middle option that cannot answer it is just the expensive option with better camouflage. Mochi Health is what remains: the arithmetic answer at $278, dethroned only by a state gap, a structural need, or a prescriber’s judgment — the three things this page deliberately cannot decide.

The same trio on best published rate: Mochi Health $278 → Henry Meds $349 → Remedy Meds $399 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Mochi Health $834, Henry Meds $1,047, Remedy Meds $1,197; 6 months — Mochi Health $1,668, Henry Meds $2,094, Remedy Meds $2,394. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

Grade the three records before trusting the three prices. On the five-point disclosure checklist (price, pharmacy, states, cancellation, source-verification): Mochi Health 5/5 · Henry Meds 3/5 · Remedy Meds 3/5. The gap between Mochi Health (5/5) and Henry Meds (3/5) is itself information: undisclosed axes are where the questions in each provider’s review earn their keep. The concrete splits — pharmacy named: Mochi Health yes, Henry Meds and Remedy Meds no — convert directly into pre-purchase emails. Every score is a computation from the dataset, contestable at the corrections desk like any other figure.

The three-way verdict compresses cleanly: Mochi Health is the default on arithmetic; Henry Meds earns the middle only where its structure (flat pricing) solves something the floor does not; and Remedy Meds’s $121/month premium over the leader — $1,452 a year, roughly 5.2 extra months of therapy at the floor rate — needs a named justification from its record, not a vibe. Insurance coverage, where it exists, outranks all three.